(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide

C32H43NO2 — CID 44563680

IUPAC(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide
SMILESC[C@H](CO)NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCc1cccc2ccccc12
InChIInChI=1S/C32H43NO2/c1-28(27-34)33-32(35)26-17-15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-21-29-23-20-24-30-22-18-19-25-31(29)30/h2,4-5,7-8,10-11,13,18-20,22-25,28,34H,3,6,9,12,14-17,21,26-27H2,1H3,(H,33,35)/b4-2-,7-5-,10-8-,13-11-/t28-/m1/s1
InChIKeyOSSYCBWLWGBDNV-VHVGVXPPSA-N
MW473.70 g/mol
LogP7.61
Rot. Bonds17

About (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide

(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide (PubChem CID 44563680) has the molecular formula C32H43NO2 and a molecular weight of 473.70 g/mol. Its IUPAC name is (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide.

Molecular Properties

Compound Name(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide
PubChem CID44563680
Molecular FormulaC32H43NO2
Molecular Weight473.70 g/mol
Exact Mass473.33
IUPAC Name(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide
SMILESC[C@H](CO)NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCc1cccc2ccccc12
InChIInChI=1S/C32H43NO2/c1-28(27-34)33-32(35)26-17-15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-21-29-23-20-24-30-22-18-19-25-31(29)30/h2,4-5,7-8,10-11,13,18-20,22-25,28,34H,3,6,9,12,14-17,21,26-27H2,1H3,(H,33,35)/b4-2-,7-5-,10-8-,13-11-/t28-/m1/s1
InChIKeyOSSYCBWLWGBDNV-VHVGVXPPSA-N
XLogP7.61
TPSA49.33 Ų
H-Bond Donors2
H-Bond Acceptors2
Rotatable Bonds17
Heavy Atoms35
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500473.70
LogP ≤ 57.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide?
The IUPAC name of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide (CID 44563680) is (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide.
What is the SMILES notation for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide?
The canonical SMILES for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide is C[C@H](CO)NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCc1cccc2ccccc12.
What is the InChIKey of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide?
The InChIKey is OSSYCBWLWGBDNV-VHVGVXPPSA-N. The full InChI is InChI=1S/C32H43NO2/c1-28(27-34)33-32(35)26-17-15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-21-29-23-20-24-30-22-18-19-25-31(29)30/h2,4-5,7-8,10-11,13,18-20,22-25,28,34H,3,6,9,12,14-17,21,26-27H2,1H3,(H,33,35)/b4-2-,7-5-,10-8-,13-11-/t28-/m1/s1.
What are the key properties of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide?
(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide has a molecular weight of 473.70 g/mol, XLogP of 7.61, 17 rotatable bonds, 2 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-19-naphthalen-1-ylnonadeca-5,8,11,14-tetraenamide is sourced from PubChem (CID 44563680), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).